Vaccinations (Measles) (% of children ages 12-23 months): Q4 in Zimbabwe
Zimbabwe: Vaccinations (Measles) (% of children ages 12-23 months): Q4 was 93.3% in 2019. ▲ Rising
Vaccinations (Measles) (% of children ages 12-23 months): Q4 in Zimbabwe, 1994–2019
Source: Household Surveys (DHS, MICS).
Analysis
Zimbabwe recorded 93.3% for vaccinations (measles) (% of children ages 12-23 months): q4 in 2019. That is the highest value across all 8 years on record.
The figure is up 11.7% over ten years.
Over the whole period, vaccinations (measles) (% of children ages 12-23 months): q4 in Zimbabwe peaked at 93.3% in 2019 and was at its lowest, 70.4%, in 2006.
That places Zimbabwe 5th out of 42 countries with data for 2019, putting it in the top 10%.
Vaccinations (Measles) (% of children ages 12-23 months): Q4 in Zimbabwe, year by year
| Year | Value | Change |
|---|---|---|
| 1994 | 84.5% | — |
| 1999 | 73.8% | -12.7% |
| 2006 | 70.4% | -4.6% |
| 2009 | 83.5% | +18.6% |
| 2011 | 86.9% | +4.1% |
| 2014 | 88.8% | +2.2% |
| 2015 | 84.5% | -4.8% |
| 2019 | 93.3% | +10.4% |
Zimbabwe compared with similar countries
- Zimbabwe's 93.3% is above the median for lower middle income countries, which is 82.3%, 1.1× the median. (20 countries reporting)
- Zimbabwe's 93.3% is above the median for Sub-Saharan Africa, which is 76.8%, 1.2× the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 79.2% | 73.8% | 84.5% | 2 |
| 2000s | 77.0% | 70.4% | 83.5% | 2 |
| 2010s | 88.4% | 84.5% | 93.3% | 4 |
Countries ranked near Zimbabwe
More health data for Zimbabwe
- Un projection of annual infant deaths, annual growth rate -1.39 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.11 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 874.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,457 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 0.9632 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0689 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9673 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is vaccinations (measles) (% of children ages 12-23 months): q4 in Zimbabwe?
- Vaccinations (measles) (% of children ages 12-23 months): q4 in Zimbabwe was 93.3% in 2019, according to Household Surveys (DHS, MICS).
- What is the highest vaccinations (measles) (% of children ages 12-23 months): q4 recorded in Zimbabwe?
- The highest recorded value was 93.3% in 2019.
- What is the lowest vaccinations (measles) (% of children ages 12-23 months): q4 recorded in Zimbabwe?
- The lowest recorded value was 70.4% in 2006.
- How does Zimbabwe rank for vaccinations (measles) (% of children ages 12-23 months): q4?
- Zimbabwe ranks 5th out of 42 countries with data for 2019.
- Is vaccinations (measles) (% of children ages 12-23 months): q4 rising or falling in Zimbabwe?
- Over the last ten years it is up 11.7%. The long-run trend across the full record is rising.
- Where does this Zimbabwe data come from?
- The figures come from Household Surveys (DHS, MICS), published as part of Vaccinations (Measles) (% of children ages 12-23 months): Q4. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Vaccinations: Percentage of children 12-23 months who have received specific vaccines by the time of the survey (according to the vaccination card or the mother's report). Children with all vaccinations refer children who have received BCG, measles, and three doses each of DPT and polio vaccine (excluding polio 0). Some MICS surveys refer children in different age groups (e.g. 18-29 months, or 15-26 months).